Syndax Pharmaceuticals (SNDX) Earnings Date & Reports

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

SNDX is expected to report earnings to fall 15.67% to -46 cents per share on October 29

Syndax Pharmaceuticals SNDX Stock Earnings Reports

Q3'26

Est.

$-0.46

Q2'26

Missed

by $0.07

Q1'26

Beat

by $0.14

Q4'25

Missed

by $0.19

Q3'25

Beat

by $0.03

The last earnings report on August 04 showed earnings per share of -55 cents, missing the estimate of -47 cents. With 527.26K shares outstanding, the current market capitalization sits at 1.59B.

View a ticker or compare two or three

SNDX

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for SNDX